Boston Scientific, a manufacturer of medical devices, agreed to acquire Devoro Medical, a developer of the WOLF Thrombectomy platform for $336m. "Clot management remains a core focus of our business, and upon commercialization, this highly differentiated technology will complement and expand our offerings to a full suite of interventional strategies for thromboemboli, which also includes the EkoSonic™ Endovascular System (EKOS) and the AngioJet™ Thrombectomy System," Jeff Mirviss, Boston Scientific Executive Vice President.